MARK2 and non-small cell lung carcinoma: Also, concurrent mutations in KRAS and LKB1 (coding a serine-threonine kinase that directly phosphorylates and activates AMPK) genes abrogated OTX015 effects in NSCLC, as previously described for JQ1 [32].